Publications by authors named "M Angeles Abengozar"

Background And Purpose: Multicatheter breast brachytherapy is a standard technique for accelerated partial breast irradiation (APBI) in early breast cancer patients. Intraoperative multicatheter breast implant (IOMBI) followed by perioperative high-dose-rate brachytherapy (PHDRBT) offers a novel and advantageous approach. We present long-term oncological, toxicity, and cosmesis outcomes for a well-experienced single institution.

View Article and Find Full Text PDF
Article Synopsis
  • Leishmaniases can present as mild skin infections or severe, life-threatening diseases, and current treatments mainly rely on chemotherapy, facing challenges like side effects and drug resistance.
  • Cyclobenzaprine (CBP), a muscle relaxant approved by the FDA, has shown promise against Leishmania in lab settings, but its mechanisms were not fully understood until this study focused on its impact on energy metabolism.
  • The research found that CBP significantly disrupts energy production in Leishmania, causing cell damage and making it a promising candidate for repurposing as a leishmanicidal drug due to its relatively mild side effects.
View Article and Find Full Text PDF

The recruitment of eosinophils into lesions is frequently associated with a favorable evolution. A feasible effector for this process is eosinophil cationic protein (ECP, RNase 3), one of the main human eosinophil granule proteins, endowed with a broad spectrum of antimicrobial activity, including parasites. ECP was active on promastigotes and axenic amastigotes (LC's = 3 and 16 μM, respectively) but, in contrast to the irreversible membrane damage caused on bacteria and reproduced by its -terminal peptides, it only induced a mild and transient plasma membrane destabilization on promastigotes.

View Article and Find Full Text PDF

Purpose: To evaluate the feasibility, early toxicity, and clinical outcomes of early-breast cancer patients in a single-arm, phase I/II study of an ultra-accelerated, four-fraction schedule of minimal breast irradiation (4f-AMBI) using a multicatheter, minimally-invasive, intraoperative tumor bed implant (MITBI) during breast-conserving surgery (BCS).

Methods And Materials: Eligible women aged >40 years with clinically and radiologically confirmed, unifocal invasive or in situ ≤3 cm tumors were considered as potential candidates for MITBI during BCS. After the pathology report, patients who met APBI criteria received ultra-accelerated four-fractions irradiation (6.

View Article and Find Full Text PDF

A new family of hybrid β,γ-peptidomimetics consisting of a repetitive unit formed by a chiral cyclobutane-containing -β-amino acid plus a -functionalized -γ-amino-l-proline joined in alternation were synthesized and evaluated as cell penetrating peptides (CPP). They lack toxicity on the human tumoral cell line HeLa, with an almost negligible cell uptake. The dodecapeptide showed a substantial microbicidal activity on parasites at 50 µM but with a modest intracellular accumulation.

View Article and Find Full Text PDF